logo
Plus   Neg
Share
Email

Arcturus Appoints Four Directors And Reaches Settlement Deal With Founder Payne

Arcturus Therapeutics Ltd. (ARCT) said that, as part of a settlement agreement, it has appointed four new independent directors, Peter Farrell, Andrew Sassine, James Barlow and Magda Marquet, to its Board, effective as of May 27, 2018.

In connection with these appointments, Stuart Collinson, Daniel Geffken, David Shapiro, and Craig Willett have resigned from the Board.

Other key terms of the settlement agreement include mutual releases of all parties and the agreement by the Company and Joseph E. Payne to terminate all pending litigation.

The settlement was approved on May 28, 2018 by the Israeli District Court.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria. Cosmetics company Revlon Inc. (REV) is reportedly considering a potential sale of parts or all of its business. According to Bloomberg, Revlon has retained financial advisers from Goldman Sachs Group Inc. to explore strategic alternatives. No deal has been reached yet, but Revlon is exploring all... China's Lenovo Group Ltd. warned it may have to raise prices of its products if the U.S. moves ahead with the decision to impose additional tariffs on Chinese goods, according to a report by Reuters. The warning by Lenovo, the world's largest PC maker, comes amid the escalating trade war between the U.S. and China that has raised concerns about the global economic outlook.